Comparative Biological and Clinical Outcomes after a Switch from a Virologically Unsuccessful First Protease Inhibitor–Containing Antiretroviral Combination to a 3‐Drug Regimen Containing Efavirenz, Nevirapine, or Abacavir
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.